These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6105058)

  • 21. Comparative disposition of sulindac and metabolites in five species.
    Duggan DE; Hooke KF; Noll RM; Hucker HB; Van Arman CG
    Biochem Pharmacol; 1978; 27(19):2311-20. PubMed ID: 103551
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterohepatic circulation of sulindac and metabolites.
    Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
    Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimethyl sulfoxide inhibits metabolic activation of sulindac.
    Swanson BN; Mojaverian P; Boppana VK; Vlasses PH; Ferguson RK
    Ann N Y Acad Sci; 1983; 411():381-2. PubMed ID: 6576719
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic disposition of 5-iminodaunorubicin in the rat.
    Peters JH; Gordon GR; Kashiwase D; Acton EM
    Cancer Res; 1984 Apr; 44(4):1453-9. PubMed ID: 6704961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disposition of [3H]diisopropylfluorophosphate in guinea pigs after inhalation.
    Scimeca JA; Martin BR
    Drug Metab Dispos; 1988; 16(4):534-9. PubMed ID: 2903019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene.
    Yuan ZX; Sikka HC; Munir S; Kumar A; Muruganandam AV; Kumar S
    Chem Res Toxicol; 2003 Dec; 16(12):1581-8. PubMed ID: 14680372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The disposition of sulindac.
    Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC
    Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibuprofen and sulindac kinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB
    Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
    Graham DY; Smith JL; Holmes GI; Davies RO
    Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
    Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
    Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics.
    Malloy MJ; Ravis WR; Pennell AT; Hagan DR; Betagari S; Doshi DH
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):286-9. PubMed ID: 7921528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs.
    Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulindac disposition when given once and twice daily.
    Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK
    Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulindac metabolism: the importance of an intact colon.
    Strong HA; Warner NJ; Renwick AG; George CF
    Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental transfer of sulindac and its active sulfide metabolite in humans.
    Kramer WB; Saade G; Ou CN; Rognerud C; Dorman K; Mayes M; Moise KJ
    Am J Obstet Gynecol; 1995 Mar; 172(3):886-90. PubMed ID: 7892880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage.
    Werner M; Birner G; Dekant W
    Chem Res Toxicol; 1996; 9(1):41-9. PubMed ID: 8924615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue distribution of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.